CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Actomyosin regulation by eph receptor signaling couples boundary cell formation to border sharpness
Authors
M Addison
J Cayuso
DG Wilkinson
Q Xu
Publication date
23 August 2019
Publisher
'eLife Sciences Publications, Ltd'
Doi
Abstract
© 2019 The Authors. Published by eLife Sciences Publications Ltd. This is an open access article available under a Creative Commons licence. The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.7554/eLife.49696.001The segregation of cells with distinct regional identity underlies formation of a sharp border, which in some tissues serves to organise a boundary signaling centre. It is unclear whether or how border sharpness is coordinated with induction of boundary-specific gene expression. We show that forward signaling of EphA4 is required for border sharpening and induction of boundary cells in the zebrafish hindbrain, which we find both require kinase-dependent signaling, with a lesser input of PDZ domain-dependent signaling. We find that boundary-specific gene expression is regulated by myosin II phosphorylation, which increases actomyosin contraction downstream of EphA4 signaling. Myosin phosphorylation leads to nuclear translocation of Taz, which together with Tead1a is required for boundary marker expression. Since actomyosin contraction maintains sharp borders, there is direct coupling of border sharpness to boundary cell induction that ensures correct organisation of signaling centres.This work was supported by the Francis Crick Institute which receives its core funding from Cancer Research UK (FC001217), the UK Medical Research Council (FC001217), and the Wellcome Trust (FC001217).Published versio
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Wolverhampton Intellectual Repository and E-theses
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:wlv.openrepository.com:243...
Last time updated on 14/03/2021
Wolverhampton Intellectual Repository and E-theses
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:wlv.openrepository.com:243...
Last time updated on 14/03/2021